Yoshio Takada

Itabashi, 1730003, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Galectin-4 contributes to the maintenance of expression and activation of multiple receptor-type kinases involved in peritoneal metastasis.

Galectin-4 contributes to the maintenance of expression and activation of multiple receptor-type kinases involved in peritoneal metastasis.

Journal: Scientific reports

Published: September 04, 2025

Inhibitory Effect of Fucoidan Analogs on Highly Metastatic Gastric Cancer Cells via Galectin-4 Inhibition.

Inhibitory Effect of Fucoidan Analogs on Highly Metastatic Gastric Cancer Cells via Galectin-4 Inhibition.

Journal: International journal of molecular sciences

Published: June 13, 2025

Lectin-Based Approaches to Analyze the Role of Glycans and Their Clinical Application in Disease.

Lectin-Based Approaches to Analyze the Role of Glycans and Their Clinical Application in Disease.

Journal: International journal of molecular sciences

Published: August 26, 2024

High expression of B3GALT5 suppresses the galectin-4-mediated peritoneal dissemination of poorly differentiated gastric cancer cells.

High expression of B3GALT5 suppresses the galectin-4-mediated peritoneal dissemination of poorly differentiated gastric cancer cells.

Journal: Glycobiology

Published: April 19, 2024

Galectin-4 Is Involved in the Structural Changes of Glycosphingolipid Glycans in Poorly Differentiated Gastric Cancer Cells with High Metastatic Potential.

Galectin-4 Is Involved in the Structural Changes of Glycosphingolipid Glycans in Poorly Differentiated Gastric Cancer Cells with High Metastatic Potential.

Journal: International journal of molecular sciences

Published: June 30, 2023

Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells.

Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: July 31, 2022

Preparation and biological activities of anti-HER2 monoclonal antibodies with multibranched complex-type N-glycans.

Preparation and biological activities of anti-HER2 monoclonal antibodies with multibranched complex-type N-glycans.

Journal: Glycobiology

Published: October 06, 2020

Novel endo-β-N-acetylglucosaminidases from Tannerella species hydrolyze multibranched complex-type N-glycans with different specificities.

Novel endo-β-N-acetylglucosaminidases from Tannerella species hydrolyze multibranched complex-type N-glycans with different specificities.

Journal: Glycobiology

Published: December 27, 2019

LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells.

LacdiNAcylation of N-glycans in MDA-MB-231 human breast cancer cells results in changes in morphological appearance and adhesive properties of the cells.

Journal: Histochemistry and cell biology

Published: September 30, 2019

Discovery of Novel Indazole Derivatives as Orally Available β3-Adrenergic Receptor Agonists Lacking Off-Target-Based Cardiovascular Side Effects.

Discovery of Novel Indazole Derivatives as Orally Available β3-Adrenergic Receptor Agonists Lacking Off-Target-Based Cardiovascular Side Effects.

Journal: Journal of medicinal chemistry

Published: March 30, 2017

Discovery of Novel Indazole Derivatives as Highly Potent and Selective Human β3-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects.

Discovery of Novel Indazole Derivatives as Highly Potent and Selective Human β3-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects.

Journal: Journal of medicinal chemistry

Published: July 01, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026